FDA inspection
Enzon Pharmaceuticals, Inc: FDA inspection ending Apr 4, 2007
FDA inspection 467267 · Voluntary Action Indicated (VAI) · South Plainfield, NJ
Key facts
| Inspection ID | 467267 |
|---|---|
| Firm | Enzon Pharmaceuticals, Inc |
| FEI number | 2245253 |
| Address | 300 Corporate Ct |
| City | South Plainfield |
| State | NJ |
| ZIP | 07080-2415 |
| Fiscal year | 2007 |
| Inspection end date | Apr 4, 2007 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data